Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION USP

Last updated on 2018-07-10 History
Report ID 46145
Drug Identification Number 02347830
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION USP
Common or Proper name ROPIVACAINE
Company Name PFIZER CANADA ULC
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL
Packaging size 10 x 20mL GVL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-17
Estimated end date
Actual end date 2018-07-06
Shortage status Resolved
Updated date 2018-07-10
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-07-10 French Compare
v10 2018-07-10 English Compare
v9 2018-06-22 French Compare
v8 2018-06-22 English Compare
v7 2018-06-18 French Compare
v6 2018-06-18 English Compare
v5 2018-05-30 French Compare
v4 2018-05-30 English Compare
v3 2018-04-18 English Compare
v2 2018-04-17 French Compare
v1 2018-04-17 English Compare